Description
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Cas No. | 950736-05-7 |
|---|---|
| Purity | ≥98% |
| Formula | C29H24F3N5O |
| Formula Wt. | 515.54 |
| IUPAC Name | N-[3-(3-{4-[(Dimethylamino)methyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide |
| Solubility | DMSO: ≥ 53 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Berger DM, Torres N, Dutia M, et al. Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. PMID: 19864136.
H+/K+ ATPase inhibitor.
Phosphodiesterase inhibitor that produces anti-...
Fluoroquinolone; topoisomerase IV and bacterial...
Fluoroquinolone; topoisomerase IV, topoisomeras...
NSAID; COX-1/2 and PDE inhibitor.
ALK and IGF-1R inhibitor.
Vitamin A derivative, acetate ester of retinol....
AurKA/B inhibitor.
Btk inhibitor.
Nitroimidazole; microtubule polymerization inhi...
VEGFR2, PDGFR, FGFR2 inhibitor.
Diketopiperazine produced by Aspergillus; micro...
Derivative of aloe-emodin, anthraquinone found ...
Diarylether; bacterial ENR binder, fatty acid s...
Thioamide; thyroid peroxidase inhibitor.
Sulfonylurea; ATP-sensitive K+ channel blocker....
CHK1 inhibitor.
SYK/JAK inhibitor
p110α PI3K inhibitor.
DPP4 inhibitor.